US · Healthcare
Biotechnology
Gossamer Bio Inc (GOSS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $49.31M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Gossamer Bio Inc (GOSS) has a reported market cap of $49.31M (data as of 2026-05-24).
The price-to-earnings (P/E) ratio for Gossamer Bio Inc (GOSS) is 25.00 (data as of 2026-05-24).
Dividend yield is not available in the current snapshot for Gossamer Bio Inc (GOSS). Check the MyAverix Finance app for the latest dividend data.
Gossamer Bio Inc (GOSS) is classified in the Healthcare sector (Biotechnology industry).
GOSS is listed on US.
Gossamer Bio Inc (GOSS) reports a net margin of 0.0% (data as of 2026-05-24).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.